American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$256M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$239M |
| 3 |
General Mills
GIS
|
+$216M |
| 4 |
Perrigo
PRGO
|
+$191M |
| 5 |
Booking.com
BKNG
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$379M |
| 2 |
WFM
Whole Foods Market Inc
WFM
|
+$235M |
| 3 |
United Parcel Service
UPS
|
+$201M |
| 4 |
Costco
COST
|
+$187M |
| 5 |
Danaher
DHR
|
+$182M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.55% |
| 2 | Industrials | 12.42% |
| 3 | Healthcare | 11.92% |
| 4 | Technology | 11.09% |
| 5 | Consumer Discretionary | 10.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Plexus
PLXS
$7.25B
| $1.47M | ﹤0.01% |
36,690
+1,941
| +6% | +$79.3K |
|
1152
Scotiabank
BNS
$110B
| $1.46M | ﹤0.01% |
27,188
-237
| -0.9% | -$12.7K |
|
1153
Future Fuel
FF
$257M
| $1.45M | ﹤0.01% |
71,312
-40,819
| -36% | -$702K |
|
|
RYL
1154
DELISTED
RYLAND GROUP INC
RYL
| $1.44M | ﹤0.01% |
36,130
-7,290
| -17% | -$310K |
|
|
HMSY
1155
DELISTED
HMS Holdings Corp.
HMSY
| $1.43M | ﹤0.01% |
74,975
-4,800
| -6% | -$104K |
|
|
GEVA
1156
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $1.4M | ﹤0.01% |
16,840
-1,160
| -6% | -$107K |
|
|
DHIL
1157
DELISTED
Diamond Hill
DHIL
| $1.4M | ﹤0.01% |
10,613
-607
| -5% | -$72.5K |
|
1158
Acadia Pharmaceuticals
ACAD
$5.07B
| $1.39M | ﹤0.01% |
57,220
-2,150
| -4% | -$54.4K |
|
|
HTWR
1159
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $1.38M | ﹤0.01% |
14,660
-860
| -6% | -$83.7K |
|
1160
Natural Gas Services Group
NGS
$474M
| $1.35M | ﹤0.01% |
44,670
-3,350
| -7% | -$99.9K |
|
1161
Clorox
CLX
$12.8B
| $1.34M | ﹤0.01% |
15,283
-524
| -3% | -$46K |
|
|
FL
1162
DELISTED
Foot Locker
FL
| $1.34M | ﹤0.01% |
28,440
+13,360
| +89% | +$555K |
|
|
ETFC
1163
DELISTED
E*Trade Financial Corporation
ETFC
| $1.33M | ﹤0.01% |
57,974
+3,146
| +6% | +$68.9K |
|
1164
Jones Lang LaSalle
JLL
$16.7B
| $1.33M | ﹤0.01% |
+11,229
| New | +$1.29M |
|
1165
Nektar Therapeutics
NKTR
$2.57B
| $1.33M | ﹤0.01% |
7,323
+1,674
| +30% | +$331K |
|
1166
Mettler-Toledo International
MTD
$28.8B
| $1.33M | ﹤0.01% |
5,645
| – | – |
|
|
CHK
1167
DELISTED
Chesapeake Energy Corporation
CHK
| $1.32M | ﹤0.01% |
273
-8
| -3% | -$39K |
|
1168
Graham Corp
GHM
$1.33B
| $1.3M | ﹤0.01% |
40,830
-2,920
| -7% | -$102K |
|
1169
Celldex Therapeutics
CLDX
$3.52B
| $1.3M | ﹤0.01% |
4,900
-117
| -2% | -$44.8K |
|
|
DLLR
1170
DELISTED
DFC GLOBAL CORP COM STK (DE)
DLLR
| $1.3M | ﹤0.01% |
147,069
+1,277
| +0.9% | +$11.4K |
|
1171
Prestige Consumer Healthcare
PBH
$2.48B
| $1.3M | ﹤0.01% |
47,612
-67,370
| -59% | -$2M |
|
1172
Travel + Leisure Co
TNL
$4.58B
| $1.29M | ﹤0.01% |
38,904
-3,448,600
| -99% | -$113M |
|
|
AUXL
1173
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $1.28M | ﹤0.01% |
46,934
-3,530
| -7% | -$93.7K |
|
1174
Ryder
R
$10.1B
| $1.27M | ﹤0.01% |
15,917
-1,159
| -7% | -$85.9K |
|
|
NEWP
1175
DELISTED
NEWPORT CORP
NEWP
| $1.27M | ﹤0.01% |
+61,201
| New | +$1.19M |
|
Similar funds
American Century Companies's Q1 2014 Portfolio in Review
As of Q1 2014, American Century Companies held 1,597 positions worth $84.6B, down 0.38% from $84.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
American Century Companies withdrew a net $2.81B in Q1 2014, closing 163 positions and reducing 614 holdings. Its most notable exit was GNC Holdings, Inc., an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, American Century Companies opened a new position in CR Bard Inc. worth $255M.
- American Century Companies's largest Q1 2014 buy was CR Bard Inc.: 1,725,410 shares worth $255M.
- American Century Companies added most to Johnson & Johnson in Q1 2014, an estimated $256M increase.
- American Century Companies's biggest Q1 2014 reduction was Apple, cutting an estimated $379M.
- American Century Companies fully exited GNC Holdings, Inc. in Q1 2014, selling an estimated $171M.
- American Century Companies's ten largest holdings make up 13% of its $84.6B portfolio in Q1 2014.
- American Century Companies opened 169 new positions and closed 163 in Q1 2014.
- American Century Companies's portfolio value fell 0.38% quarter-over-quarter to $84.6B.
Based on American Century Companies's 13F filing for Q1 2014, filed 5 May 2014.